OIL Brent has reached the threshold of $60 for the first time in more than a year with a mix of... The post Daily market commentary: Brent...
China’s national regulator has approved Sinovac Biotech’s COVID-19 vaccine for use by the general public. This is the The post China approves Sinovac’s coronavirus vaccine appeared...
UK Won't Introduce "Vaccine Passports", Minister Says Authored by Alexander Zhang via The Epoch Times, The UK government will not introduce “vaccine passports,” but people will...
Even 'Scientist' Models Now Forecast The COVID Scourge Ending By The Summer The covid pandemic was front and center today in economic news, when its impact...
After the first three weeks of January, the MSCI AC World index in US dollar terms had posted gains of 3.6%. In the last week, global...
Horos Asset Management commentary for the fourth quarter ended December 31, 2020 discussing an approach to the Austrian Business Cycle Theory. Q4 2020 hedge fund letters,...
America's Lost Decade In Fertility Results In 5.8 Million Fewer Babies The global economy is not prepared for an ongoing global population crash, as deglobalization has been kicked...
"A Wake-Up Call" - AstraZeneca Jab Fails To Prevent Mutated COVID Strain From South Africa After data was shared last week suggesting that the AstraZeneca-Oxford COVID...
The Astrazeneca/Oxford vaccine offers only limited protection against mild disease caused by the South African variant of the coronavirus
The decision to go south for the winter during the ongoing pandemic is a complex one, informed by factors such as availability of recreational opportunities and...
Vaccine selfies are just the tip of the iceberg of doctor frustration over Canada's fragmented vaccine rollout.
Amazon and its subsidiary Whole Foods have been cleared of wrongdoing by a US federal judge for allegedly illegally punishing employees who chose to show support...
Bristol Myers Squibb announced on Feb. 5 that the US Food and Drug Administration (FDA) has approved its lymphoma drug, Breyanzi, a CAR-T (chimeric antigen receptor...
Johnson & Johnson has submitted an application to the US Food and Drug Administration (FDA) for emergency use authorization (EUA) of its investigational single-dose COVID-19 vaccine...
Russia's "Sputnik V" COVID Vaccine A Surprise Global Hit Bloomberg, one of the most implicitly pro-western media outlets in existence, has finally admitted, after months of...
Supreme Court Strikes Down California Indoor Worship Ban As President Biden staffs his committee on "Supreme Court Reform" (otherwise known as court packing, an issue Democrats...
The Rapidly Failing EU Authored by Alasdair Macleod via GoldMoney.com, It is not widely realised that the EU concept is on its last legs. The bureaucratic...
Hospitalizations Fall In NY, But Not As Quickly As Other COVID Hotspots: Live Updates Summary: Hospitalizations fall in NY, but not as fast as other hotspots...
The Biden administration is exploring every option for increasing manufacturing of Johnson & Johnson’s Covid-19 vaccine, which is under regulatory review, and said on Feb. 5...
The official unemployment rate was 6.3% in January—matching the maximum unemployment rate of the early 2000s downturn—and the official number of unemployed workers was 10.1 million,...
Biden Summons Troops To Help With COVID Vaccinations, Expands DPA Update (1230ET): Biden is also reportedly planning to expand his use of the Defense Production Act...
A lively start to the year It’s been an surprisingly lively start to the year, with recent weeks being dominated by retail traders taking on hedge...
Biden Follows Trump's Lead, Summons Troops To Help With COVID Vaccinations While some in the media questioned President Trump's rhetoric about "counting on the military" to...
Johnson & Johnson’s Janssen Biotech submitted an application to the U.S. Food and Drug Administration for emergency use authorization (EUA) for a single-dose Covid-19 vaccine.
Less than one week after posting a positive first-look at Phase III vaccine data, Maryland-based Novavax began the rolling review process for authorization of NVX-CoV2373 in...
AstraZeneca reported that the company's Phase III KESTREL trial of Imfinzi (durvalumab) failed to meet the primary endpoint of improving overall survival compared to the EXTREME treatment...
AstraZeneca expects results from the U.S. clinical trial of the company's Covid-19 vaccine in the next four to six weeks, the pharma firm’s research chief Mene...
A new study report in Science suggests SARS-CoV-2 and its mutated new variants can evade immune responses via the selective deletion of small sections of the virus’s...
National Trends in Disability Employment (nTIDE) – issued semi-monthly by Kessler Foundation and the University of New Hampshire Credit: Kessler Foundation East Hanover, NJ – February...
Ocugen (OCGN) announced it had finalized its deal with India-based Bharat Biotech top commercialize COVAXIN COVID-19 vaccine already in use in India